Based on current research, NfL might be a valuable diagnostic [254], differential diagnostic [255], prognostic biomarker [256,257], and also can help to predict the outcome [258,259] and monitor disease activity and therapeutic response [258] in a variety of neurological disorders, including MS. Here, NEFL is linked to myeloid sarcoma.